Skip to content

Vericel VCEL Total Revenue

Total Revenue at other companies

Stryker logo
StrykerSYK
$6.02B+2.6%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$2.09B+9.3%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$66.55M+11.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$24.06B+9.9%

Segments

By product

See full
M A C I Implants and kits$56.4M+21.8%
MACI implants, kits, and instruments$41.51M+30.4%
Epicel$10.89M+119%
Biopsy kits$606K+1.7%

Other financials

Income statement

See full
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's total revenue?
Vericel (VCEL) reported total revenue of $68.43M in Q1 2026.
How has Vericel's total revenue changed year-over-year?
Vericel's total revenue increased by 30.1% year-over-year, from $52.6M to $68.43M.
What is the long-term trend for Vericel's total revenue?
Over 4 years (2021 to 2025), Vericel's total revenue has grown at a 15.3% compound annual growth rate (CAGR), from $156.18M to $276.26M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.